SCHEMBL7305440

SCHEMBL7305440

[O]c1c(F)cc(F)c2cccc(F)c12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 3/20 0.33
CYP2C9 P11712 3/20 0.33
CYP2C19 P33261 3/20 0.33
CES2 O00748 2/20 0.33
CES1 P23141 2/20 0.33
ALDH1A1 P00352 1/20 0.33
AR P10275 3/20 0.33
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HPRT1 P00492 1/20 0.32
PGR P06401 1/20 0.32
AHR P35869 2/20 0.32
PARP1 P09874 2/20 0.32
CYP2D6 P10635 1/20 0.31
DAO P14920 1/20 0.31
DDO Q99489 1/20 0.31
PTGER4 P35408 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5252029 0.78 CYP1A2 (0.33) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL20356033 0.77 CYP1A2 (0.35) CYP1A2CYP3A4CYP2C9CYP2C19CES2
SCHEMBL5252035 0.74 ACHE (0.36) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL7305545 0.71 CES2 (0.34) CYP1A2CYP3A4CYP2C9CYP2C19CES2
SCHEMBL20356037 0.71 DAO (0.36) CYP1A2CYP3A4CYP2C9CYP2C19CES2
SCHEMBL30366470 0.71 DAO (0.36) CYP1A2CYP3A4CYP2C9CYP2C19CES2
SCHEMBL20356032 0.68 CYP1A2 (0.35) CYP1A2CYP3A4CYP2C9CYP2C19CES2
SCHEMBL7300314 0.68 CES2 (0.33) CES2CES1ARNPC1HPGD
SCHEMBL331592 0.67
SCHEMBL14197895 0.67 HPRT1 (0.39) HPRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed